Close Menu

plant genomics

NEW YORK (GenomeWeb News) - Some plants, especially angiosperms, have monstrously large genomes, posing a unique set of problems for which researchers conducting plant genomic studies have developed a number of clever solutions.

NEW YORK (GenomeWeb News) – UK researchers will use £2.4 million ($3.6 million) in new funding to conduct genome sequencing and analysis to understand how a "devastating fungus" attacks ash trees and how some trees resist those attacks, the Biotechnology and Biological Sciences Research Council s

NEW YORK (GenomeWeb News) – Europe has launched a new funding call that will fuel new plant genomics and molecular biology research with an expected €20 million ($25.7 million), with the aim of backing international research consortia to address major agricultural and climate-related problems.

NEW YORK (GenomeWeb News) – The National Science Foundation has provided $10 million for two programs at Cold Spring Harbor Laboratory and Oregon State University to develop public data resources containing genomic information about important crop plants, such as corn, rice, wheat, barley, and

NEW YORK (GenomeWeb News) – A pair of studies in Nature today are revealing the repertoire of microbial organisms residing in and around the roots of Arabidopsis plants.

By Molika Ashford
This story was originally published Feb. 17.

NEW YORK (GenomeWeb News) – Genome British Columbia and Genome Canada today announced nearly C$4.3million (US$4.3 million) in funding for the development of genomic diagnostics aimed at forest disease.

NEW YORK (GenomeWeb News) – Evogene today reported a 31 percent revenue spike for the third quarter ended Sept. 30.

Pages

A UK study on mixing SARS-CoV-2 vaccines is expanding to include vaccines developed by additional companies, according to the Guardian.

According to Science, the US National Academy of Sciences is poised to eject two members accused of sexual harassment.

In Nucleic Acids Research this week: machine learning approach to detect DNA-bound proteins, CRISPR-based method for activating specific gene targets, and more.

The FDA and CDC call for a pause in administering Johnson & Johnson's SARS-CoV-2 vaccine while reports of rare blood clots are looked into, reports the Wall Street Journal.